Touchlight
London, UK
Program data pending ClinicalTrials.gov matching
—
Not Assessed
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCircular ssDNA (mbDNA), Cell-free linear dsDNA (dbDNA), mRNA templates, AAV starting material, DNA vaccines, Non-viral gene therapy DNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
—
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
—
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press10 articles
Broad modality coverage (6 modalities)
Recent News 10 articles
GSK inks deal with CDMO Touchlight for access to its ‘doggybone DNA’ tech - Fierce Pharma
Touchlight Expands mbDNA™ Portfolio with New Circular DNA Architectures for Advanced Therapies - Biotech Newswire
After Touchlight's Pfizer pact, CDMO Curia gets its hands on firm's 'doggybone' DNA platform - Fierce Pharma
as a rapid and scalable solution to industrial lentiviral vector manufacturing - Nature
GSK Partners with Touchlight for mRNA Vaccine Development Using dbDNA Technology - SynBioBeta
Touchlight’s Hampton, UK Facility Receives GMP Certification from MHRA - Contract Pharma
AskBio, Touchlight Restructure Former JV, Touchlight AAV - Contract Pharma
Lonza, Touchlight partner on 'doggybone DNA' development - Fierce Pharma
CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution - Labiotech.eu
Production of lentiviral vectors using novel, enzymatically produced, linear DNA - Nature
Represent this organization? Contact us to verify or update this profile.